Acute exacerbations of chronic type B hepatitis are accompanied by increased T cell responses to hepatitis B core and e antigens. Implications for hepatitis B e antigen seroconversion - PubMed (original) (raw)

Acute exacerbations of chronic type B hepatitis are accompanied by increased T cell responses to hepatitis B core and e antigens. Implications for hepatitis B e antigen seroconversion

S L Tsai et al. J Clin Invest. 1992 Jan.

Abstract

T cell proliferative responses to hepatitis B virus-encoded envelope antigen (S + preS2 + preS1), recombinant core antigen (HBcAg), and natural hepatitis B e antigen (HBeAg) were examined in 22 HBeAg-positive patients with chronic type B hepatitis and 17 healthy hepatitis B surface antigen (HBsAg) carriers. The results showed that HBeAg-positive patients had (a) higher levels of T cell responses to HBcAg/HBeAg than those of healthy HBsAg carriers (P less than 0.001 and P less than 0.01, respectively); (b) a further increase in these T cell responses during acute exacerbations (P less than 0.05 and P less than 0.05, respectively); (c) subsidence in the T cell responses to HBcAg/HBeAg after recovery from acute exacerbations and HBeAg seroconversion, whereas the responses would persist at high levels if the patients did not enter a clinical remission; and (d) low levels of T cell responses to S + preS2 + preS1 either before or after HBeAg seroconversion. The appearance of increasing T cell responses to HBcAg/HBeAg usually occurred in the early phase of acute exacerbations. These findings imply that HBcAg/HBeAg-specific T cells play an important role in the exacerbations of chronic hepatitis B and in HBeAg seroconversion. HBcAg/HBeAg-specific precursor T cell frequencies were serially studied in selected cases by limiting dilution assay. Elevation (two- to fourfold) of HBcAg/HBeAg-specific precursor T cell frequencies contributed to the increase of HBcAg/HBeAg-specific T cell proliferation during acute exacerbations.

PubMed Disclaimer

Cited by

HBeAg induces neutrophils activation impairing NK cells function in patients with chronic hepatitis B.
Feng Z, Fu J, Tang L, Bao C, Liu H, Liu K, Yang T, Yuan JH, Zhou CB, Zhang C, Xu R, Wang FS. Feng Z, et al. Hepatol Int. 2024 Aug;18(4):1122-1134. doi: 10.1007/s12072-024-10689-z. Epub 2024 Jun 3. Hepatol Int. 2024. PMID: 38829576
Systemic cytokine and viral antigen-specific responses in hepatitis D virus RNA positive versus HDV RNA negative patients.
Joshi SS, Sadler M, Patel NH, Osiowy C, Fonseca K, Coffin CS. Joshi SS, et al. Front Med (Lausanne). 2023 Oct 9;10:1125139. doi: 10.3389/fmed.2023.1125139. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37877022 Free PMC article.
HBeAg-Negative/Anti-HBe-Positive Chronic Hepatitis B: A 40-Year-Old History.
Bonino F, Colombatto P, Brunetto MR. Bonino F, et al. Viruses. 2022 Jul 30;14(8):1691. doi: 10.3390/v14081691. Viruses. 2022. PMID: 36016312 Free PMC article. Review.
KASL clinical practice guidelines for management of chronic hepatitis B.
Korean Association for the Study of the Liver (KASL). Korean Association for the Study of the Liver (KASL). Clin Mol Hepatol. 2022 Apr;28(2):276-331. doi: 10.3350/cmh.2022.0084. Epub 2022 Apr 1. Clin Mol Hepatol. 2022. PMID: 35430783 Free PMC article. No abstract available.
Transaminase Elevations during Treatment of Chronic Hepatitis B Infection: Safety Considerations and Role in Achieving Functional Cure.
Vaillant A. Vaillant A. Viruses. 2021 Apr 23;13(5):745. doi: 10.3390/v13050745. Viruses. 2021. PMID: 33922828 Free PMC article. Review.

References

1. Lancet. 1989 Sep 9;2(8663):588-91 - PubMed
1. J Immunol. 1987 Jul 15;139(2):539-44 - PubMed
1. Hepatology. 1987 Jul-Aug;7(4):758-63 - PubMed
1. Hepatology. 1987 Jul-Aug;7(4):764-72 - PubMed
1. J Immunol. 1987 Sep 15;139(6):2050-8 - PubMed

Acute exacerbations of chronic type B hepatitis are accompanied by increased T cell responses to hepatitis B core and e antigens. Implications for hepatitis B e antigen seroconversion - PubMed (original) (raw)